Priority review for Roche’s Hemlibra

6th June 2018 Uncategorised 0

Roche’s Hemlibra will get a speedy review in the US for adults and children with haemophilia A without factor VIII inhibitors.

More: Priority review for Roche’s Hemlibra
Source: News